Kim Payne to Gene Expression Regulation, Leukemic
This is a "connection" page, showing publications Kim Payne has written about Gene Expression Regulation, Leukemic.
Connection Strength
0.767
-
IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia. Blood. 2020 09 24; 136(13):1520-1534.
Score: 0.174
-
Casein Kinase II (CK2), Glycogen Synthase Kinase-3 (GSK-3) and Ikaros mediated regulation of leukemia. Adv Biol Regul. 2017 08; 65:16-25.
Score: 0.139
-
Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia. J Biol Chem. 2016 Feb 19; 291(8):4004-18.
Score: 0.125
-
Cell cycle-specific function of Ikaros in human leukemia. Pediatr Blood Cancer. 2012 Jul 15; 59(1):69-76.
Score: 0.094
-
Tumor suppression in T cell leukemia--the role of Ikaros. Leuk Res. 2010 Apr; 34(4):416-7.
Score: 0.082
-
Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia. Leukemia. 2021 05; 35(5):1267-1278.
Score: 0.045
-
The Current Genomic and Molecular Landscape of Philadelphia-like Acute Lymphoblastic Leukemia. Int J Mol Sci. 2020 Mar 22; 21(6).
Score: 0.042
-
Application of vitamin D and vitamin D analogs in acute myelogenous leukemia. Exp Hematol. 2017 06; 50:1-12.
Score: 0.034
-
High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement. Oncotarget. 2016 Aug 02; 7(31):49722-49732.
Score: 0.033